Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker MRNA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | MRNA Moderna, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 6, 2026 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 30, 2026 | MRNA Moderna, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 30, 2026 | MRNA Moderna, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 1, 2026 | MRNA Moderna, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 1, 2026 | MRNA Moderna, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Sep 1, 2026 | MRNA Moderna, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Sep 1, 2026 | MRNA Moderna, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 31, 2026 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 8, 2026 | MRNA Moderna, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 8, 2026 | MRNA Moderna, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 11, 2026 | MRNA Moderna, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 11, 2026 | MRNA Moderna, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| May 1, 2026 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 5, 2026 | MRNA Moderna, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 13, 2026 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 11, 2026 | MRNA Moderna, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 11, 2026 | MRNA Moderna, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | MRNA Moderna, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 5, 2026 | MRNA Moderna, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 24, 2025 | MRNA Moderna, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Nov 24, 2025 | MRNA Moderna, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 20, 2025 | MRNA Moderna, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 13, 2025 | MRNA Moderna, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Nov 6, 2025 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 1, 2025 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 5, 2025 | MRNA Moderna, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 1, 2025 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 14, 2025 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 13, 2025 | MRNA Moderna, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 7, 2024 | MRNA Moderna, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:02 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances